TY - JOUR
T1 - Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia :
T2 - between bench and bedside
AU - Cabrera-Fuentes, H. A
AU - Alba-Alba, Corina
AU - Aragones, Julian
AU - Bernhagen, Jürgen
AU - Boisvert, William A.
AU - Bøtker, Hans Erik
AU - Cesarman-Maus, Gabriela
AU - Fleming, Ingrid
AU - García-Dorado, David
AU - Lecour, Sandrine
AU - Liehn, Elisa
AU - Marber, Michael S.
AU - Marina, Nephtali
AU - Mayr, Manuel
AU - Perez-Mendez, Oscar
AU - Miura, Tetsuji
AU - Ruiz-Meana, Marisol
AU - Salinas-Estefanon, Eduardo M.
AU - Ong, Sang-Bing
AU - Schnittler, Hans J.
AU - Sanchez-Vega, Jose T.
AU - Sumoza-Toledo, Adriana
AU - Vogel, Carl-Wilhelm
AU - Yarullina, Dina
AU - Yellon, Derek M.
AU - Preissner, Klaus T.
AU - Hausenloy, Derek J.
PY - 2015
Y1 - 2015
N2 - Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. Although a number of pathological situations such as ischemia-reperfusion injury or atherosclerosis can be simulated and manipulated in diverse animal models, also to challenge new drugs for intervention, patient studies are the ultimate litmus test to obtain unequivocal information about the validity of biomedical concepts and their application in the clinics. Thus, the open and bidirectional exchange between bench and bedside is crucial to advance the field of ischemic heart disease with a particular emphasis of understanding long-lasting approaches in cardioprotection.
AB - Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. Although a number of pathological situations such as ischemia-reperfusion injury or atherosclerosis can be simulated and manipulated in diverse animal models, also to challenge new drugs for intervention, patient studies are the ultimate litmus test to obtain unequivocal information about the validity of biomedical concepts and their application in the clinics. Thus, the open and bidirectional exchange between bench and bedside is crucial to advance the field of ischemic heart disease with a particular emphasis of understanding long-lasting approaches in cardioprotection.
KW - Atherosclerosis
KW - Cardioprotection
KW - Cardiovascular disease
KW - Endothelial permeability
KW - Extracellular RNA
KW - High-density lipoprotein
KW - Hypoxia
KW - Inflammation
KW - Ischemia/reperfusion injury
KW - Macrophage polarization
KW - MicroRNAs
KW - Mitochondria
KW - Platelet dysfunction
KW - Vascular biology
U2 - 10.1007/s00395-015-0527-0
DO - 10.1007/s00395-015-0527-0
M3 - Article
C2 - 26667317
SN - 0300-8428
VL - 111
JO - Basic Research in Cardiology
JF - Basic Research in Cardiology
ER -